引用本文:洪 城,陈海明.慢性血栓栓塞性肺动脉高压的介入治疗[J].中国临床新医学,2020,13(9):869-873.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 61次   下载 58 本文二维码信息
码上扫一扫!
分享到: 微信 更多
慢性血栓栓塞性肺动脉高压的介入治疗
洪 城,陈海明
510010 广东,呼吸疾病国家重点实验室,广州医科大学附属第一医院,广州呼吸健康研究院
摘要:
[摘要] 慢性血栓栓塞性肺动脉高压(CTEPH)是肺栓塞的潜在致命结果。目前肺动脉内膜剥脱术(PEA)是首选的治疗方法,但多种因素限制了其临床应用和开展。对于不能行PEA治疗的CTEPH患者,经皮球囊肺动脉成形术是近年来发展迅速的一种能够改善患者临床症状、降低肺动脉压力和肺血管阻力并改善患者预后的新的介入治疗方法。
关键词:  慢性血栓栓塞性肺动脉高压  肺动脉内膜剥脱术  经皮球囊肺动脉成形术
DOI:10.3969/j.issn.1674-3806.2020.09.05
分类号:R 544.1+6
基金项目:
Interventional treatment of chronic thromboembolic pulmonary hypertension
HONG Cheng, CHEN Hai-ming
State Key Laboratory of Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangdong 510010 China
Abstract:
[Abstract] Chronic thromboembolic pulmonary hypertension(CTEPH) is a potentially lethal outcome of pulmonary embolism. At present, pulmonary endarterectomy(PEA) is the preferred treatment method for CTEPH, but many factors limit its clinical application and development.For CTEPH patients who can not be treated with PEA, percutaneous balloon pulmonary angioplasty(BPA) is a new interventional therapy developed rapidly in recent years, which can improve the clinical symptoms, reduce the pulmonary artery pressure and pulmonary vascular resistance of the patients, and improve their prognoses.
Key words:  Chronic thromboembolic pulmonary hypertension(CTEPH)  Pulmonary endarterectomy(PEA)  Percutaneous balloon pulmonary angioplasty(BPA)